(Q42610772)

3 November 2017

Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide (English)

1 reference

3 November 2017

0 references

0 references

1 reference

10

Robert J Ferrante

1 reference

3 November 2017

Bruno P Imbimbo

4

1 reference

ORCID Public Data File 2021

author name string

Nadia Moretto

1

1 reference

3 November 2017

Angelo Bolchi

2

1 reference

3 November 2017

Claudio Rivetti

3

1 reference

3 November 2017

Gino Villetti

5

1 reference

3 November 2017

Vladimiro Pietrini

6

1 reference

3 November 2017

Luciano Polonelli

7

1 reference

3 November 2017

Steven Del Signore

8

1 reference

3 November 2017

Karen M Smith

9

1 reference

3 November 2017

Simone Ottonello

11

1 reference

3 November 2017

language of work or name

English

0 references

publication date

31 January 2007

1 reference

Journal of Biological Chemistry

3 November 2017

1 reference

3 November 2017

282

1 reference

3 November 2017

15

1 reference

3 November 2017

11436-11445

1 reference

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

3 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Immunotherapeutic Approaches to Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Current progress in beta-amyloid immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Pubertal changes in biochemical markers of growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Immunotherapy for Alzheimer's disease and other dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Alzheimer vaccine: amyloid-beta on trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Self-assembly of Abeta(1-42) into globular neurotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: toward safer and effective vaccines against Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Alzheimer's disease and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Papillomavirus-like particles are an effective platform for amyloid-beta immunization in rabbits and transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Conformational Abs recognizing a generic amyloid fibril epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Engineering novel binding proteins from nonimmunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Isolation of peptide aptamers that inhibit intracellular processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

BioVision: an application for the automated image analysis of histological sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

Immunotherapy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609690200

21 January 2018

Identifiers

DOI

10.1074/JBC.M609690200

1 reference

release_yle2saflxzfbzaupz7juqnd2bi

3 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yle2saflxzfbzaupz7juqnd2bi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference